Brain radiotherapy combined with targeted therapy for HER2-positive breast cancer patients with brain metastases
L Tang, W Zhang, L Chen - Breast Cancer: Targets and Therapy, 2024 - Taylor & Francis
Background Research on the sequencing of brain radiotherapy and targeted chemotherapy
after brain metastasis (BM) in HER2-positive breast cancer patients is limited and …
after brain metastasis (BM) in HER2-positive breast cancer patients is limited and …
DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer
KJ Borm, ST Behzadi, J Hörner-Rieber, D Krug… - Strahlentherapie und …, 2024 - Springer
Purpose The aim of this review was to evaluate the existing evidence for radiotherapy for
brain metastases in breast cancer patients and provide recommendations for the use of …
brain metastases in breast cancer patients and provide recommendations for the use of …
Breast cancer subtypes and mortality of breast cancer patients with brain metastasis at diagnosis: a population-based study
DJ He, DQ Yu, QM Wang, ZY Yu… - … : The Journal of …, 2021 - journals.sagepub.com
Background Brain metastasis is an important cause of breast cancer-related death. Aim We
evaluated the relationships between breast cancer subtype and prognosis among patients …
evaluated the relationships between breast cancer subtype and prognosis among patients …
Comparison of initial and sequential salvage brain-directed treatment in patients with 1–4 vs. 5–10 brain metastases from breast cancer (KROG 16–12)
JS Kim, K Kim, W Jung, KH Shin, SA Im, HJ Kim… - Breast Cancer Research …, 2023 - Springer
Purpose We aimed to compare the initial and salvage brain-directed treatment and overall
survival (OS) between patients with 1–4 brain metastases (BMs) and those with 5–10 from …
survival (OS) between patients with 1–4 brain metastases (BMs) and those with 5–10 from …
Valid Analysis of Brain-Specific Progression-Free Survival
S Armbruster, EB Ludmir, LJ Wei - JAMA oncology, 2024 - jamanetwork.com
Chen and colleagues1 conducted a clinical trial to investigate whether the addition of an
induction treatment of bevacizumab, etoposide, and cisplatin (BEEP) would improve …
induction treatment of bevacizumab, etoposide, and cisplatin (BEEP) would improve …
[HTML][HTML] Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast …
JS Kim, K Kim, W Jung, KH Shin, SA Im, YB Kim… - The Breast, 2021 - Elsevier
Background To investigate outcomes of salvage whole-brain radiotherapy (WBRT) for
recurrent brain metastases (BM) from breast cancer (BC), to identify prognostic factors of …
recurrent brain metastases (BM) from breast cancer (BC), to identify prognostic factors of …
[HTML][HTML] The Pattern of Care for Brain Metastasis from Breast Cancer over the Past 10 Years in Korea: A Multicenter Retrospective Study (KROG 16-12)
JS Kim, K Kim, W Jung, KH Shin… - … : Official Journal of …, 2022 - synapse.koreamed.org
Purpose We aimed to investigate manifestations and patterns of care for patients with brain
metastasis (BM) from breast cancer (BC) and compared their overall survival (OS) from 2005 …
metastasis (BM) from breast cancer (BC) and compared their overall survival (OS) from 2005 …
Cognitive function of patients receiving whole brain radiotherapy for brain metastases from lung cancer and guidance strategies based on intelligent software.
Y Chen, L Zhang, JF Huang… - Česká a Slovenská …, 2022 - search.ebscohost.com
English Aim: The aim of this study was to investigate cognitive functions of patients receiving
whole brain radiotherapy (WBRT) for brain metastases (BM) from lung cancer, and to …
whole brain radiotherapy (WBRT) for brain metastases (BM) from lung cancer, and to …